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Introduction
Bloodstream infections (BSIs) are the most com­
mon nosocomial infections among neonates, associa­
ted with a significantly increased risk of fatality (Stoll 
et al., 2002). Newborns, especially those with very low 
birth weight (VLBW) are primarily at risk of develop­
ing late­onset BSIs (LO­BSIs), caused by organisms 
acquired perinatally or postnatally, usually as a  con­
sequence of nosocomial transmission. The main risk 
factors for LO­BSI include prematurity, prolonged stay 
in a neonatal intensive care unit (NICU) and admini­
stration of invasive procedures (Ozkan et al., 2014). 
Consequently, the improved survival rates of small 
premature infants experiencing long stays in modern 
NICUs, which are better equipped for life­saving inten­
sive care, has been a major factor in the increase in 
LO­BSI caused by Gram­negative bacteria (Cordero 
et al., 2004; Wojkowska­Mach et al., 2013). Enterobac­
teriaceae are second only to coagulase­negative staphy­
lococci (CoNS) in causing LO­BSIs (Karlowicz et al., 
2000; Lutsar et al., 2014). Prolonged use of broad­spec­
trum antibiotics in NICUs is associated with the occur­
rence of multi­drug resistant (MDR) bacteria. Selec­
tion of more broadly resistant Gram­negative enteric 
bacteria is linked with outbreaks of bacterial disease in 
NICUs (Cordero et al., 2004).
Nosocomial isolates such as Escherichia coli and 
Klebsiella sp. often have extended spectrum β­lactamase 
(ESBL) phenotypes, and E. coli strains carrying these 
enzymes have disseminated into the community. One 
of the best examples of this trend is the global spread 
of the clonal E. coli sequence type (ST) 131 (ST131), 
which expresses CTX­M enzymes. (Birgy et al., 2013) 
In contrast, among Klebsiella strains, relatively few of 
the serotypes (particularly K1 and K2) appear to be 
linked with invasive strains. Also, the hypermucovis­
cous phenotype, strongly associated with the presence 
of rpmA and magA genes, is a virulence marker in 
clinical strains (Jung et al., 2013). In Klebsiella pneumo­
niae, CTX­M­15 is mainly associated with quinolone­
resistant strains, belonging to ST11 clone (Damjanova 
et al., 2008; Oteo et al., 2009).
Despite many reports of ESBL­producing isolates 
among Polish hospitals, no report has been found 
about the molecular epidemiology of Enterobacteriaceae 
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causing BSI in neonates. Here, we collected clinical iso­
lates from Enterobacteriaceae family bacteria originat­
ing from BSIs of neonates hospitalized in six Polish 
NICUs to determine their antibiotic resistance pro­
files, virulence gene prevalence, and the epidemiologi­
cal and genetic relationships among the isolates. Here 
we have focused on detailed molecular studies, data 
about epidemiology of bloodstream infections in new­
borns are included in other manuscripts (Wojkowska­
Mach et al., 2014).
Experimental
Materials and Methods
Study population. Prior to the study, a confirm­
atory ethics vote for the data collected in the Polish 
Neonatology Surveillance Network (PNSN) for the 
scientific purpose was approved by the Bioethics 
Committee of Jagiellonian University Medical College 
(No KBET/221/B/2011). 
Continuous prospective target surveillance of infec­
tions was conducted from 1/1/2009 through 12/31/2011 
at Polish NICUs (only teaching hospitals) which par­
ticipated in PNSN. These tertiary NICUs provided care 
for 20% of all VLBW infants born in Poland annually. 
The surveillance included infants hospitalized in these 
NICUs whose birth weights were < 1500 grams (VLBW) 
at birth until they achieved a weight of 1800 grams or 
died. The study covered 1,695 newborns. The general 
fatality case rate was 16.3%. All VLBW infants of sus­
pected or documented infected were subject to registra­
tion regardless of the time of occurrence according to 
criteria of Gastmeier et al. (2004) when they had clini­
cal signs of a bloodstream infection (BSI) (Gastmeier 
et al., 2004).
•	 at	least	2	of	the	following:	temperature	>	38°C	or	
<	36.5°C	 or	 temperature	 instability,	 tachycardia	
or bradycardia, apnea, prolonged capillary refill, 
metabolic acidosis, hypoglycemia and other signs 
of bloodstream infections such as lethargy; 
•	 and	 patients	 who	 had	 1	 of	 the	 following	 crite­
ria:	 C-reactive	 protein	 >	2.0	mg/dl,	 immature/
total	neutrophil	ratio	(I/T	ratio)	>	0.2,	leukocytes	
< 5000/μl and platelets < 10000/μl.
LO-BSI	was	defined	when	diagnosed	>	72 hours	after	
delivery. Clinical sepsis represented an infant where 
signs of infection existed but on blood culture a causa­
tive organism was not identified.
Central venous catheter (CVC)­associated BSI 
(CVC­BSI) and peripheral intravenous catheter (PVC)­
associated BSI (PVC­BSI) were defined as infections 
associated with the use of a central or peripheral venous 
catheter within the preceding 48  hours prior to the 
onset of the infection (Gastmeier et al., 2004).
Bacterial strains. The present study examined 55 
Enterobacteriaceae family isolates originating from 
BSIs: 4 from early onset infections (EOI), 51 from LOI. 
The majority originated from NICUs VI and II (25 and 
12, respectively). The remainder were from V (8), I (5), 
III (3) and IV (2). 
Culture and species identification. All blood 
specimens of at least 1 ml were injected into an aerobic 
blood culture bottle (Bactec Plus 26 Aerobic; Becton 
Dickinson, Poland), and cultured on MacConkey agar, 
Columbia	agar	(at	37°C,	each	for	24	h)	and	Sabouraud	
agar	(at	37°C,	48	hours)	(all	from	BIOCORP,	Poland).	
Collection and identification of the bacterial strains 
was performed in the local microbiology laboratories of 
each hospital. Isolates were identified by the automated 
identification system (VITEK 2; bioMérieux, Warsaw, 
Poland).	Bacterial	strains	were	stored	at	−70°C	and	sent	
to Department of Microbiology, Krakow.
Antimicrobial susceptibility tests. Isolates were 
tested using disk diffusion antimicrobial susceptibil­
ity methods on Mueller­Hinton agar plates accord­
ing to the current European Committee on Antimi­
crobial Susceptibility Testing (EUCAST) guidelines 
using clinical breakpoint tables v. 3.1 (http://www. 
eucast. org v.3.1, accessed: 11.02.2013). All discs were 
obtained from Oxoid, Basingstoke. ESBL activity was 
detected using a  modified double­disk synergy test 
(Drieux et al., 2008). ESBL­positive strains resistant 
to at least two other groups of antibiotics were consid­
ered to be MDR.
DNA isolation. DNA templates were extracted 
using a Genomic Mini kit (A&A Biotechnology, Poland) 
according to manufacturer’s instructions.
Polymerase chain reaction (PCR) for extended-
spectrum β-lactamase genes and virulence factor 
screening. PCR was performed to identify the presence 
of blaCTX­M, blaSHV and blaTEM genes (Chmielarczyk et al., 
2013; Monstein et al., 2007), products were sequenced 
by commercial company (Genomed, Warsaw, Poland). 
E. coli was checked for the presence of selected viru­
lence genes as described elsewhere (Chmielarczyk et al., 
2013; Johnson and Stell, 2000; Watt et al., 2003). 
The isolates were classified to 1 of the 4 main E. coli 
phylogenetic groups (A, B1, B2,and D) (Chmielarczyk 
et al., 2013; Clermont et al., 2000).
K. pneumoniae was tested for the presence of rmpA 
(regulator of mucoid phenotype A), magA (mucovis­
cosity­associated gene A), wabG (involved in the bio­
synthesis of the outer core lipopolysaccharide), uge 
(encoding uridine diphosphate galacturonate 4­epime­
rase, which is responsible for capsule biosynthesis), 
kfu (iron uptake system), and allS (encoding the acti­
vator of the allantoin regulon) (Brisse et al., 2009). 
PCR was performed with primer pairs specific for 
the K. pneumoniae capsule gene cluster (cpsK1, cpsK2) 
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(Fang et al., 2007; Turton et al., 2008). NCTC 5054 and 
NCTC 5055 were used as positive controls for cpsK1 
and cpsK2, respectively.
Pulsed-field gel electrophoresis (PFGE). All iso­
lates were analyzed using the standardized PFGE pro­
tocol developed at the Centers for Disease Control and 
Prevention by the PulseNet program. XbaI (Thermo 
Scientific) was used for DNA digestion. The digested 
products were separated on a CHEF III PFGE system 
(BioRad, Warsaw, Poland) in 0.5 × Tris­borate­EDTA 
buffer	at	14°C	at	6	V	for	20	h	with	a	ramped	pulse	time	
of 2.2–54.2 s for E. coli	and	14°C	at	6	V	for	22	h	with	
a ramped pulse time of 2–35 s for K. pneumoniae, Kleb­
siella oxytoca, Enterobacter cloacae and Serratia marces­
cens. GelCompar (Applied Maths, Kortrijk, Belgium) 
was used for cluster analysis with the unweighted pair 
group method with an arithmetic mean and the Dice 
coefficient	similarity	require	to	be	>	90%	for	the	pattern	
to be considered as belonging to the same type.
Multilocus sequence typing (MLST). MLST for 
E. coli was performed in accordance with (Wirth et al., 
2006) (http://mlst.ucc.ie/mlst/dbs/Ecoli), for K. pneu­
moniae was performed in accordance with (Diancourt 
et al., 2005) (http://www.pasteur.fr/recherche/genopole/
PF8/mlst/Kpneumoniae.html). 
Results
The surveillance group contained 1,695 newborns 
with birth weight below 1500 g. Data on gestational age, 
mode of delivery, birth weight, multiple birth were pre­
viously published (Wojkowska­Mach et al., 2014). In 
the study group, 100 cases of Enterobacteriaceae BSI 
were registered. Among all the etiological factors for 
BSI, bacteria belonging to Enterobacteriaceae family 
were responsible for 15.2% of such infections. The inci­
dence rate for Enterobacteriaceae BSIs was 5.9%, while 
the fatality rate was 15%. The fatality rate for E. coli was 
26.0% and for Klebsiella sp. 10.0% (p = 0.09). Of the 
55  Enterobacteriaceae isolates included in our study, 
there were 24 E. coli, 16 K. pneumoniae, 4 K. oxytoca, 
5 E. cloacae, 1 Enterobacter sakazakii, 4 S. marcescens 
and 1 Morganella morganii (Table I).
The CVC utilization rate was 0.45 and the PVC utili­
zation rate was 0.16 (calculated by dividing the number 
of days of CVC/PVC by the total number of patient 
days). Among the infections caused by E. coli, 20.8% 
of LO­BSIs were associated with CVC use, while 8.3% 
were associated with PVC use. Among the LO infec­
tions caused by K. pneumoniae, 43.75% were associated 
with CVC and 18.75% with PVC.
I (n = 5) 1 ST141 unique 1 ST153 unique 2
 1 ST73 unique
II (n = 12) 4 ST131 unique    1 3
 2 ST69 identical
   (the same patient)
 1 ST69 unique
 1 ST75 unique
III (n = 3)    1 ST336 unique   1 1
IV (n = 2)         2
V (n = 8) 2 ST131 unique 2 ST17 identical
      (the same patient)  1
 1 ST141 unique
 1 ST69 unique
 1 ST543 unique
VI (n = 25) 3 ST998 unique 5 ST336 clone A  3  1
 1 ST131 unique 2 ST11 clone B
 1 ST141 unique 2 ST6 clone C
 1 ST69 unique 1 ST6 unique
 1 ST95 unique 1 ST153 unique
 1 ST569 unique 1 ST870 unique
 1 non unique
  typeable
Table I
Participation of particular isolates in species and NICU.
NICU
Escherichia coli (n = 24) Klebsiella pneumoniae (n = 16) Entero­
bacter sp.
(n = 6)
Klebsiella
oxytoca
(n = 4)
Serratia
marcescens
(n = 4)
Morganella
morganii
(n = 1)ST Pulsotype ST Pulsotype
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The highest level of resistance among E. coli isolates 
was observed against AMP (91.7%), AMC (54.2%), 
SXT (41.7%) and ATM (33.3%). The highest level of 
resistance among K. pneumoniae isolates was observed 
against AMP (100%), ATM (81.3%), AMC (56.3%), all 
the cephalosporins investigated herein (56.3%), and 
CIP (43.8%) (Table II). The ESBL phenotype was found 
among 16 isolates (29%), with nine K. pneumoniae, six 
E. coli and one E. cloacae. 
Molecular characterization showed that all ESBL­
positive isolates carried the blaCTX­M gene: 15 of them 
had CTX­M­15 and one had CTX­M­3. Eleven iso­
lates (68.8%) harbored the TEM­1 gene together with 
the CTX­M gene. Five isolates harbored the SHV­11 
gene and one harbored SHV­1 together with CTX­M. 
Four isolates harbored CTX­M­15 gene together with 
TEM­1 gene and SHV­11 gene. One isolates harbored 
CTX­M­15 gene together with TEM­1 gene and SHV­1 
gene. Ten of the ESBL­positive strains (5 E. coli and 
5 K. pneumoniae) were regarded as MDR types. 
The most frequently detected genes among the 
E. coli isolates were iron­related genes including fhuA 
(91.7%), fecA (75%), iutA (58.3%), fyuA (54.2%), iroN 
(50%) and iucC (50%), iha (8.3%). The most frequently 
detected adhesion gene was fimH (found in 83.3% of the 
isolates). The ibeA gene was found in 37.5% of isolates, 
while the neuC gene was found in 20.8% of isolates.
Sixteen (66.6%) isolates clustered in the ECOR 
group B2, 6 (25.0%) in D, 1 (4.2%) in A, and 1 (4.2%) 
in group B1.
None of the K. pneumoniae strains tested here were 
the capsular K1 or K2 type. Additionally, the magA 
gene was not identified in the isolates. In contrast, 
the gene uge was detected in all of the K. pneumoniae 
strains, while wabG was present in 11 of them (68.8%). 
Only one isolate harbored allS (no 75), while another 
harbored kfu and rpm genes (no 220).
PFGE typing demonstrated that almost all of the 24 
E. coli isolates had unique pulsotypes. Two strains with 
identical pulsotypes were isolated from the same patient. 
Penicillins
Ampicillin 22 (91.7) 16 (100) nd 4 (100) nd nd
Amoxicillin­clavulanate  13 (54.2) 9 (56.3) nd 2 (50) nd nd
Piperacillin­tazobactam 0 (0) 2 (12.5) 1 (16.7) 0 (0) 0 (0) 0 (0)
Cephalosporins
Cefepime 6 (25) 9 (56.3) 0 (0) 0 (0) 0 (0) 0 (0)
Cefotaxime 5 (20.8) 9 (56.3) 2 (33.3) 0 (0) 1 (25) 1 (100)
Ceftazidime 6 (25) 9 (56.3) 1 (16.7) 0 (0) 1 (25) 0 (0)
Cefuroxime  6 (25) 9 (56.3) nd 0 (0) nd nd
Carbapenems
Doripenem 1 (4.2) 3 (18.8) 0 (0) 0 (0) 0 (0) 0 (0)
Ertapenem 2 (8.3) 3 (18.8) 2 (33.3) 0 (0) 0 (0) 1 (100)
Imipenem 1 (4.2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Meropenem 1 (4.2) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Monobactams
Aztreonam 8 (33.3) 13 (81.3) 2 (33.3) 1 (25) 1 (25) 1 (100)
Fluoroquinolones
Ciprofloxacin 5 (20.8) 7 (43.8) 0 (0) 0 (0) 0 (0) 0 (0)
Aminoglycosides
Amikacin 2 (8.3) 2 (12.5) 0 (0) 0 (0) 0 (0) 0 (0)
Gentamicin 3 (12.5) 3 (18.8) 0 (0) 0 (0) 0 (0) 0 (0)
Tobramycin 6 (25) 8 (50) 0 (0) 0 (0) 0 (0) 1 (100)
Tetracyclines
Tigecycline 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Miscellaneous
Chloramphenicol 1 (4.2) 3 (18.8) 0 (0) 0 (0) 0 (0) 0 (0)
Trimethoprim­sulfamethoxazole 10 (41.7) 6 (37.5) 0 (0) 0 (0) 0 (0) 0 (0)
Table II
Non­susceptible strains among different species of Enterobacteriaceae family.
Escherichia coli
n = 24 (%)
Klebsiella 
pneumoniae
n = 16 (%)
Enterobacter sp.
n = 6 (%)
Klebsiella
oxytoca
n = 4 (%)
Serratia 
marcescens
n = 4 (%)
Morganella
morganii
n = 1 (%)
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MLST typing revealed 10 different sequence types; these 
included ST131 (7 isolates), ST69 (5), ST141 (3), ST998 
(3), ST73 (1), ST75 (1), ST95 (1), ST543 (1) and ST569 
(1). One isolate could not be typed. Four among the 
ST131 isolates were from NICU II (Fig. 1). PFGE typ­
ing of 16 K. pneumoniae strains showed eight different 
pulsotypes. Five isolates from NICU VI belonged to one 
clone A. Those isolates were detected in 2009, 2010 and 
2011. The mortality connected with those strains was 
21.4%. Clone B consisted of two isolates similarly to 
clone C while the remaining five isolates had unique pul­
sotypes. MLST typing revealed seven different sequence 
types: ST 336 (6 isolates), ST6 (3), ST 11 (2) ST17 (2), 
ST153 (1), ST321 (1), and ST 870 (1). The main clone 
identified by PFGE was compatible with ST 336 (Fig. 2). 
PFGE typing of the E. cloacae strains revealed unique 
pulsotypes. Among K. oxytoca, two strains with identi­
cal pulsotypes were from the same patient, as was in the 
case for S. marcescens (data not shown).
Discussion
Enterobacteriaceae remain one of the most impor­
tant, albeit not the most frequent, cause of BSIs. Sep­
ticaemia or BSI in neonates is an important cause 
of neonatal mortality and morbidity in developing 
Fig. 1. Dendrogram of E. coli isolates. NICU was designated by Roman numerals. Asterisks indicate isolates derived from the same patient.
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countries and K. pneumoniae and E. coli are prominent 
causative agents. In a study of 6215 infants admitted 
to the National Institute of Child Health and Human 
Development (NICHD) Neonatal Research Network 
(NRN) centers, 70% of first episode late­onset infec­
tions were caused by Gram­positive organisms, with 
coagulase­negative staphylococci accounting for 48% 
of the infections; however, the death rates were highest 
for infants infected with E. coli. (Karlowicz et al., 2000) 
Studies conducted by Makhoul et al. (2005) showed that 
mortality rate was about 4 times higher for infections 
caused by E. coli and 6 times higher for K. pneumo­
niae than for CoNS infections. Gram­negative bacilli 
(GNB) have been shown to be the non­dominant group 
of etiological risk factors for BSI, representing 20–30% 
of the infections in some studies (Graham et al., 2006; 
Mitt et al., 2014; Nagao, 2013). A study conducted by 
Cordero et al. (2004) showed that 20% of BSI episodes 
were caused by GNB, of which 15% were Enterobacte­
riaceae. Identification of these microorganisms in our 
study group was 15.2% and, importantly, infection with 
these etiological agents has been shown to be connected 
with high mortality rates in neonates (15%). Stoll et al. 
(2011) has described E. coli as the major causative patho ­ 
gen of BSIs in preterm infants and the second most 
common cause of BSIs in term infants. Vergnano et al. 
(2011) indicated that E. coli was the third most common 
microorganism isolated from neonates and reported 
a prevalence of 13% in the UK, whereas in Germany 
the prevalence was 4.8% (Geffers et al., 2008), which 
is about three times less than that observed in NICUs 
in the present study. Unfortunately, E. coli is frequently 
associated with severe infections and is the leading 
cause of sepsis­related mortality among VLBW infants. 
Indeed, E. coli accounted for 24.5% of EOI of neonates 
in the United States (Weston et al., 2011) and 14.6% 
in Polish VLBW infants (Chmielarczyk et al., 2014). 
In the present study, other Enterobacteriaceae family 
microorganisms such as Klebsiella spp. and Enterobacter 
spp. were markedly less common, similar to other stud­
ies (Cordero et al., 2004; Geffers et al., 2008; Lombardi 
et al., 2014; Nagao, 2013; Vergnano et al., 2011).
Crossing the skin barrier provides a direct route of 
invasion for bacteria; therefore, insertion of a CVC and 
the length of its duration in situ are risk factors for the 
development of a BSI. Lombardi et al. (2014) showed 
that in the neonatal pathology ward CVC infections 
reached 36.3% among Gram­negative bacteria, and 
Fig. 2. Dendrogram of K. pneumoniae isolates. NICU was designated by Roman numerals.
Detected clones were marked by frames. Asterisks indicate isolates derived from the same patient.
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Klebsiella spp. were the most frequently isolated. This 
result is similar to our data.
E. coli and Klebsiella spp. isolated from NICUs in this 
study have different epidemiology to each other; hence, 
they require different surveillance and infection con­
trol. According to PFGE results, E. coli comprised dif­
ferent clones, while among the K. pneumoniae isolates, 
some showed high genetic similarity. Similar findings 
have been reported previously by other authors. (Castro 
et al., 2010; Wojkowska­Mach et al., 2013) Of the six 
NICUs we investigated, the majority of the Enterobac­
teriaceae isolates were from NICU VI, where Klebsiella 
dominated; this finding may be related to clonal spread 
of these bacteria. The Klebsiella clones detected in our 
study belong to four sequence types (ST): ST6, ST11, 
ST17 and ST336, of which ST11 and ST17 are known 
pathogens and colonizers widely distributed in Europe 
(Damjanova et al., 2008; Oteo et al., 2009).
The MLST technique showed that seven E. coli 
strains belonged to ST131, but according to the PFGE 
results, these strains had unique pulsotypes and came 
from three different centers; hence, they are assumed 
not to be clonally spread. It has been reported that 
strains belonging to the same ST do not always cluster 
in a single branch based on cluster analysis of PFGE 
patterns (Vimont et al., 2008). ST131 is often reported 
in adults and recently also in children and neonates, and 
is probably transmitted between mothers and neonates 
(Denkel et al., 2014). The spread of ESBL­producing 
ST131 E. coli in the community, especially during the 
neonatal period, is a cause for serious concern (Birgy 
et al., 2013). Recently, a  CTX­M­15 ESBL­positive 
E. coli ST131 clone, belonging to the B2 phylogenetic 
group and characterised by a particular antimicrobial 
resistance and high virulence potential, became a major 
public health problem especially in developing coun­
tries (Brisse et al., 2012; Clermont et al., 2009).
The microorganisms responsible for neonatal BSI 
have changed over time and vary from place to place. 
Prolonged use of broad­spectrum antibiotics in NICUs 
is associated with the current epidemic of MDR Gram­
negative bacteria. Biedenbach et al. (2004) reported that 
the neonatal sepsis rate from Klebsiella spp. was higher 
in Latin America than in North America and was cor­
related with the use of extended­spectrum antibiotics. 
Klebsiella spp. and E. coli had the highest level of resist­
ance to ampicillin, amoxicillin and aztreonam, which 
may have been caused by frequent administration of 
these drugs. Studies about antibiotic consumption con­
ducted on the Polish NICUs have shown that beta­lac­
tams were administred in more than 50% of infections 
(Rozanska et al., 2012). In our study, higher levels of 
antibiotic resistance (and more ESBL­positive strains) 
were observed among Klebsiella strains, probably as 
a result of the epidemic clone detected in NICU VI.
The E. coli isolates studied here were more likely to 
posses the ibeA gene than those derived from urinary 
and respiratory tract infections (Chmielarczyk et al., 
2013). Soto et al. found that strains causing EOI harbored 
a higher frequency of the ibeA gene (Soto et al., 2008). 
Among Klebsiella sp. only some of the isolates possessed 
virulence genes such as rpmA or kfu. None of the iso­
lates possessed K1 or K2 serotypes. As the capsule is 
a major virulence factor for K. pneumoniae (Cortes et al., 
2002), information about the prevalence of the capsular 
types in such infections is an essential component of 
infection prevention and control (Pan et al., 2013). 
According to the results, contact isolation is required 
when a patient is colonized or infected by a microor­
ganism which is transmitted by direct physical contact. 
The presented results have shown that reliable adher­
ence to that principle by the personnel is necessary 
when Klebsiella spp. is highly level of endemic or in 
case of epidemic. However, data about E. coli showed 
that precautions should be different and regimen about 
hand hygiene is insufficient. In the case of E. coli sur­
veillance on people who take care of a neonate includ­
ing mother and people performing Kangaroo care, 
could be performed. Infection prevention should also 
require intensive education and preparing procedures 
about Kangaroo care, feeding and milk expression 
(including milk storage) (Guzman­Cottrill et al., 2013).
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